⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Drugs Made In America Acquisition II Corp. Ordinary Shares

$10.17
+0.00 (+0.00%)

Market Capitalization:

$647.83M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Drugs Made In America Acquisition II Corp. Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

+0.00(+0.00%)
Open$10.17
Close$10.17
Low$10.17
Low Change0.00 (0.00%)
High$10.17
High Change+0.00 (+0.00%)
Range$0.00
Volume800
Dollar Volume$8.14K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.02(-0.15%)
Open$10.19
Close$10.17
Low$10.16
Low Change-0.03 (-0.25%)
High$10.19
High Change+0.00 (+0.00%)
Range$0.03
Volume4.58K
Dollar Volume$46.58K

Premarket Yesterday

*No Trades in Segment

Drugs Made In America Acquisition II Corp. News

There is no current news for this stock at the moment.

Drugs Made In America Acquisition II Corp. Top Trades

Drugs Made In America Acquisition II Corp.'s top trade so far today returned +0.00%, while the top short trade returned 0.00%.

Drugs Made In America Acquisition II Corp. Moving Averages

5 Day Moving Average (SMA5)$10.16
10 Day Moving Average (SMA10)$10.15
20 Day Moving Average (SMA20)$10.13
50 Day Moving Average (SMA50)$10.10
100 Day Moving Average (SMA100)$10.06
200 Day Moving Average (SMA200)

Drugs Made In America Acquisition II Corp. Statistics

Average Volume (30 Days)
P/E Ratio (Current)
EPS (Current)
Dividend Yield
Free Cash Flow
Cash Ratio
Current Ratio
Quick Ratio
Debt to Equity
Enterprise Value
EV to EBITDA
EV to Sales
Price to Book
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets
Return on Equity

Drugs Made In America Acquisition II Corp. Stock Splits

There have been no stock splits for Drugs Made In America Acquisition II Corp. (DMII).

Drugs Made In America Acquisition II Corp. Dividends

There have been no dividends for Drugs Made In America Acquisition II Corp. (DMII).